Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

The ARMS2 A69S Polymorphism Is Associated with Delayed Rod-Mediated Dark Adaptation in Eyes at Risk for Incident Age-Related Macular Degeneration.

Mullins RF, McGwin G Jr, Searcey K, Clark ME, Kennedy EL, Curcio CA, Stone EM, Owsley C.

Ophthalmology. 2019 Apr;126(4):591-600. doi: 10.1016/j.ophtha.2018.10.037. Epub 2018 Oct 31.

PMID:
30389424
2.

Association of risk genotypes of ARMS2/LOC387715 A69S and CFH Y402H with age-related macular degeneration with and without reticular pseudodrusen: a meta-analysis.

Jabbarpoor Bonyadi MH, Yaseri M, Nikkhah H, Bonyadi M, Soheilian M.

Acta Ophthalmol. 2018 Mar;96(2):e105-e110. doi: 10.1111/aos.13494. Epub 2017 Jun 8. Review.

3.

Delayed Rod-Mediated Dark Adaptation Is a Functional Biomarker for Incident Early Age-Related Macular Degeneration.

Owsley C, McGwin G Jr, Clark ME, Jackson GR, Callahan MA, Kline LB, Witherspoon CD, Curcio CA.

Ophthalmology. 2016 Feb;123(2):344-51. doi: 10.1016/j.ophtha.2015.09.041. Epub 2015 Oct 30.

4.

Association of Single-Nucleotide Polymorphisms in Age-Related Macular Degeneration With Pseudodrusen: Secondary Analysis of Data From the Comparison of AMD Treatments Trials.

Lin LY, Zhou Q, Hagstrom S, Maguire MG, Daniel E, Grunwald JE, Martin DF, Ying GS; CATT Research Group.

JAMA Ophthalmol. 2018 Jun 1;136(6):682-688. doi: 10.1001/jamaophthalmol.2018.1231.

5.

Associations between abnormal rod-mediated dark adaptation and health and functioning in older adults with normal macular health.

Owsley C, Huisingh C, Jackson GR, Curcio CA, Szalai AJ, Dashti N, Clark M, Rookard K, McCrory MA, Wright TT, Callahan MA, Kline LB, Witherspoon CD, McGwin G Jr.

Invest Ophthalmol Vis Sci. 2014 May 22;55(8):4776-89. doi: 10.1167/iovs.14-14502.

6.

Comparison of ARMS2/LOC387715 A69S and CFH Y402H risk effect in wet-type age-related macular degeneration: a meta-analysis.

Jabbarpoor Bonyadi MH, Yaseri M, Nikkhah H, Bonyadi M, Nazari R, Soheilian M.

Int Ophthalmol. 2019 Apr;39(4):949-956. doi: 10.1007/s10792-018-0853-y. Epub 2018 Feb 8. Review.

PMID:
29423786
7.

ARMS2 increases the risk of early and late age-related macular degeneration in the European Eye Study.

Chakravarthy U, McKay GJ, de Jong PT, Rahu M, Seland J, Soubrane G, Tomazzoli L, Topouzis F, Vingerling JR, Vioque J, Young IS, Sofat R, Hingorani AD, Fletcher AE.

Ophthalmology. 2013 Feb;120(2):342-8. doi: 10.1016/j.ophtha.2012.08.004. Epub 2012 Oct 23.

PMID:
23098369
8.

Association of ARMS2/LOC387715 A69S, CFH Y402H, and CFH I62V polymorphisms with retinal angiomatous proliferation compared with typical age-related macular degeneration: a meta-analysis.

Jabbarpoor Bonyadi MH, Yaseri M, Bonyadi M, Soheilian M.

Int Ophthalmol. 2017 Dec;37(6):1397-1409. doi: 10.1007/s10792-016-0413-2. Epub 2016 Dec 22. Review.

PMID:
28005184
9.

Age-related macular degeneration and association of CFH Y402H and LOC387715 A69S polymorphisms in a Turkish population.

Soysal Y, Inan UÜ, Küsbeci T, Imirzalioğlu N.

DNA Cell Biol. 2012 Mar;31(3):323-30. doi: 10.1089/dna.2011.1214. Epub 2011 Jul 26.

PMID:
21790300
10.

Rapid detection of CFH (p.Y402H) and ARMS2 (p.A69S) polymorphisms in age-related macular degeneration using high-resolution melting analysis.

Mello E, Falsini B, Zuppi C, Giardina B, Concolino P, Capoluongo E.

Clin Chem Lab Med. 2012 Jan 13;50(6):1031-4. doi: 10.1515/cclm-2011-0859.

PMID:
22706242
11.

Lens status influences the association between CFH polymorphisms and age-related macular degeneration: findings from two population-based studies in Singapore.

Wong CW, Liao J, Cheung GC, Khor CC, Vithana EN, Wang JJ, Mitchell P, Aung T, Wong TY, Cheng CY.

PLoS One. 2015 Mar 18;10(3):e0119570. doi: 10.1371/journal.pone.0119570. eCollection 2015.

12.

CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration.

Klein ML, Francis PJ, Rosner B, Reynolds R, Hamon SC, Schultz DW, Ott J, Seddon JM.

Ophthalmology. 2008 Jun;115(6):1019-25. doi: 10.1016/j.ophtha.2008.01.036.

PMID:
18423869
13.

Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration.

Smailhodzic D, Klaver CC, Klevering BJ, Boon CJ, Groenewoud JM, Kirchhof B, Daha MR, den Hollander AI, Hoyng CB.

Ophthalmology. 2012 Feb;119(2):339-46. doi: 10.1016/j.ophtha.2011.07.056. Epub 2011 Nov 30.

PMID:
22133792
14.

Cumulative effect of risk alleles in CFH, ARMS2, and VEGFA on the response to ranibizumab treatment in age-related macular degeneration.

Smailhodzic D, Muether PS, Chen J, Kwestro A, Zhang AY, Omar A, Van de Ven JP, Keunen JE, Kirchhof B, Hoyng CB, Klevering BJ, Koenekoop RK, Fauser S, den Hollander AI.

Ophthalmology. 2012 Nov;119(11):2304-11. doi: 10.1016/j.ophtha.2012.05.040. Epub 2012 Jul 26.

PMID:
22840423
15.

Single-Nucleotide Polymorphisms Associated With Age-Related Macular Degeneration and Lesion Phenotypes in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Maguire MG, Ying GS, Jaffe GJ, Toth CA, Daniel E, Grunwald J, Martin DF, Hagstrom SA; CATT Research Group.

JAMA Ophthalmol. 2016 Jun 1;134(6):674-81. doi: 10.1001/jamaophthalmol.2016.0669.

16.

Susceptibility to advanced age-related macular degeneration and alleles of complement factor H, complement factor B, complement component 2, complement component 3, and age-related maculopathy susceptibility 2 genes in a Mexican population.

Buentello-Volante B, Rodriguez-Ruiz G, Miranda-Duarte A, Pompa-Mera EN, Graue-Wiechers F, Bekker-Méndez C, Ayala-Ramirez R, Quezada C, Rodríguez-Loaiza JL, Zenteno JC.

Mol Vis. 2012;18:2518-25. Epub 2012 Oct 11.

17.

CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration.

Awh CC, Lane AM, Hawken S, Zanke B, Kim IK.

Ophthalmology. 2013 Nov;120(11):2317-23. doi: 10.1016/j.ophtha.2013.07.039. Epub 2013 Aug 21.

PMID:
23972322
18.

Longitudinal Study of Dark Adaptation as a Functional Outcome Measure for Age-Related Macular Degeneration.

Chen KG, Alvarez JA, Yazdanie M, Papudesu C, Wong WT, Wiley HE, Keenan TD, Chew EY, Ferris FL 3rd, Cukras CA.

Ophthalmology. 2019 Jun;126(6):856-865. doi: 10.1016/j.ophtha.2018.09.039. Epub 2018 Sep 29.

PMID:
30278196
19.

The ARMS2 A69S variant and bilateral advanced age-related macular degeneration.

Schwartz SG, Agarwal A, Kovach JL, Gallins PJ, Cade W, Postel EA, Wang G, Ayala-Haedo J, Spencer KM, Haines JL, Pericak-Vance MA, Scott WK.

Retina. 2012 Sep;32(8):1486-91. doi: 10.1097/IAE.0b013e318240a540.

20.

The contribution of genetic factors to phenotype and progression of drusen in early age-related macular degeneration.

Dietzel M, Pauleikhoff D, Arning A, Heimes B, Lommatzsch A, Stoll M, Hense HW.

Graefes Arch Clin Exp Ophthalmol. 2014 Aug;252(8):1273-81. doi: 10.1007/s00417-014-2690-7. Epub 2014 Jun 28.

PMID:
24970616

Supplemental Content

Support Center